Plasmid DNA vaccines are effective in the absence of IFNγ

Virology

Volumn 263, Issue 1, 1999, Pages 175-183

  Hassett, Daniel E ^a   Zhang, Jie ^a   Whitton, J Lindsay ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G2A;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CYTOKINE PRODUCTION; IMMUNOGENICITY; IMMUNOSTIMULATION; INTERFERON PRODUCTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS LOAD;

ANIMALIA; ARENAVIRUS; BACTERIA (MICROORGANISMS); CHORIOMENINGITIS VIRUS; DNA VIRUSES; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; ZEA MAYS;

EID: 0033543985     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9957     Document Type: Article

References (43)

1. Ballas Z. K., Rasmussen W. L., Krieg A. M. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157:1996;1840-1845.
2. Barry M. A., Lai W. C., Johnston S. A. Protection against mycoplasma infection using expression-library immunization. Nature. 377:1995;632-635.
3. Ciernik I. F., Berzofsky J. A., Carbone D. P. Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes. J. Immunol. 156:1996;2369-2375.
4. Corr M., Tighe H., Lee D., Dudler J., Trieu M., Brinson D. C., Carson D. A. Costimulation provided by DNA immunization enhances antitumor immunity. J. Immunol. 159:1997;4999-5004.
5. Dalton D. K., Pitts-Meek S., Keshav S., Figari I. S., Bradley A., Stewart T. A. Multiple defects of immune cell function in mice with disrupted interferon-g genes. Science. 259:1993;1739-1742.
6. Davis H. L., Weeratna R., Waldschmidt T. J., Tygrett L., Schorr J., Krieg A. M. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160:1998;870-876.
7. Donnelly J. J., Ulmer J. B., Liu M. A. DNA vaccines. Life Sci. 60:1997;163-172.
8. Feltquate D. M., Heaney S., Webster R. G., Robinson H. L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158:1997;2278-2284.
9. Fu T. M., Guan L., Friedman A., Schofield T. L., Ulmer J. B., Liu M. A., Donnelly J. J. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge. J. Immunol. 162:1999;4163-4170.
10. Gurunathan S., Sacks D. L., Brown D. R., Reiner S. L., Charest H., Glaichenhaus N., Seder R. A. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with leishmania major. J. Exp. Med. 186:1997;1137-1147.
11. Hassett D. E., Whitton J. L. DNA Immunization. Trends in Microbiol. 4:1996;307-312.
12. Hassett D. E., Zhang J., Whitton J. L. Neonatal DNA immunization with an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge. J. Virol. 71:1997;7881-7888.
13. Huang S., Hendriks W., Althage A., Hemmi S., Bluethmann H., Kamijo R., Vilcek J., Zinkernagel R. M., Aguet M. Immune response in mice that lack the interferon-γ receptor. Science. 259:1993;1742-1745.
14. Kagi D., Ledermann B., Burki K., Seiler P., Odermatt B., Olsen K. J., Podack E. R., Zinkernagel R. M., Hengartner H. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 369:1994;31-37.
15. Klinman D. M., Yi A. K., Beaucage S. L., Conover J., Krieg A. M. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc. Natl. Acad. Sci. USA. 93:1996;2879-2883.
16. Krieg A. M., Yi A.-K., Matson S., Waldschmidt T. J., Bishop G. A., Teasdale R., Koretzky G. A., Klinman D. M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546-549.
17. Leclerc C., Deriaud E., Rojas M., Whalen R. G. The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA. Cell Immunol. 179:1997;97-106.
18. Moldoveanu Z., Love-Homan L., Huang W. Q., Krieg A. M. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine. 16:1998;1216-1224.
19. Moskophidis D., Battegay M., Bruendler M. A., Laine E., Gresser I., Zinkernagel R. M. Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon. J. Virol. 68:1994;1951-1955.
20. Muller U., Steinhoff U., Reis L. F. L., Hemmi S., Pavlovic J., Zinkernagel R. M., Aguet M. Functional role of type I and type II interferons in antiviral defense. Science. 264:1994;1918-1921.
21. Murali-Krishna K., Altman J. D., Suresh M., Sourdive D. J., Zajac A. J., Miller J. D., Slansky J., Ahmed R. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity. 8:1998;177-187.
22. Neujahr D. C., Reich C. F., Pisetsky D. S. Immunostimulatory properties of genomic DNA from different bacterial species. Immunobiology. 200:1999;106-119.
23. Oxenius A., Martinic M. M., Hengartner H., Klenerman P. CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines. J. Virol. 73:1999;4120-4126.
24. Pedroza Martins L., Lau L. L., Asano M. S., Ahmed R. DNA vaccination against persistent viral infection. J. Virol. 69:1995;2574-2582.
25. Raz E., Tighe H., Sato Y., Corr M., Dudler J. A., Roman M., Swain S. L., Spiegelberg H. L., Carson D. A. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. USA. 93:1996;5141-5145.
26. Rodriguez F., An L. L., Harkins S., Zhang J., Yokoyama M., Widera G., Fuller J. T., Kincaid C., Campbell I. L., Whitton J. L. DNA immunization with minigenes: Low frequency of memory CTL and inefficient antiviral protection are rectified by ubiquitination. J. Virol. 72:1998;5174-5181.
27. Rodriguez F., Zhang J., Whitton J. L. DNA immunization: Ubiquitination of a viral protein enhances CTL induction, and antiviral protection, but abrogates antibody induction. J. Virol. 71:1997;8497-8503.
28. Sato Y., Roman M., Tighe H., Lee D., Corr M., Nguyen M., Silverman G., Lotz M., Carson D. A., Raz E. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science. 273:1996;352-354.
29. Schirmbeck R., Bohm W., Reimann J. DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors. J. Immunol. 157:1996;3550-3558.
30. + T cells. Nature. 1999.
31. Snapper C. M., Paul W. E. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science. 236:1987;944-947.
32. Stacey K. J., Sweet M. J., Hume D. A. Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157:1996;2116-2122.
33. Sur S., Wild J. S., Choudhury B. K., Sur N., Alam R., Klinman D. M. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J. Immunol. 162:1999;6284-6293.
34. Tishon A., Lewicki H., Rall G., von Herrath M. G., Oldstone M. B. A. An essential role for type 1 interferon-gamma in terminating persistent viral infection. Virology. 212:1995;244-250.
35. Tolley N. D., Tsunoda I., Fujinami R. S. DNA vaccination against Theiler's murine encephalomyelitis virus leads to alterations in demyelinating disease. J. Virol. 73:1999;993-1000.
36. Uchijima M., Yoshida A., Nagata T., Koide Y. Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium. J. Immunol. 161:1998;5594-5599.
37. Walker P. S., Scharton-Kersten T., Krieg A. M., Love-Homan L., Rowton E. D., Udey M. C., Vogel J. C. Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms. Proc. Natl. Acad. Sci. USA. 96:1999;6970-6975.
38. Walsh C. M., Matloubian M., Liu C. C., Ueda R., Kurahara C. G., Christensen J. L., Huang M. T., Young J. D., Ahmed R., Clark W. R. Immune function in mice lacking the perforin gene. Proc. Natl. Acad. Sci. USA. 91:1994;10854-10858.
39. Weeratna R., Brazolot Millan C. L., Krieg A. M., Davis H. L. Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides. Antisense Nucleic Acid Drug Dev. 8:1998;351-356.
40. Whitton J. L., Rodriguez F., Zhang J., Hassett D. E. DNA immunization: Mechanistic studies. Vaccine. 17:1999;1612-1619.
41. Yokoyama M., Zhang J., Whitton J. L. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Virol. 69:1995;2684-2688.
42. Zarozinski C. C., Fynan E. F., Selin L. K., Robinson H. L., Welsh R. M. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J. Immunol. 154:1995;4010-4017.
43. Zimmermann S., Egeter O., Hausmann S., Lipford G. B., Rocken M., Wagner H., Heeg K. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J. Immunol. 160:1998;3627-3630.